KRT18 and cancer: Malignant cells were identified using epithelial markers such as EPCAM and KRT18, and nonmalignant cells were annotated as myeloid immune cells, B cells, plasma cells, T cells and cancer-associated fibroblasts according to canonical markers (Fig. 4a–c; Supplementary Fig. 4a).